mpm bioventures iiiqp lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active mpm bioventures iiiqp lp • boston ma how do i update this listing mpm bioventures iiiqp is based out of boston whalewisdom has at least  dg filings in our database for mpm bioventures iiiqp summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from mpm bioventures iiiqp lp enter your email address below and choose submit your email cancel contact info mpm bioventures iiiqp lp co mpm asset management boston ma     business phone    recent sec filings sc da filed on   filed on  sc ga filed on   filed on  sc g filed on  sc da filed on  sc da filed on  sc da filed on  current dg holdings stock sector shares held market value rank source source date enteromedics inc etrm health care    d  epirus biopharmaceuticals inc com eprsq health care    d  radius health rdus health care    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free mpm bioventures iiiqp lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors mpm bioventures iiiqp lp check out list of companies and businesses related to mpm bioventures iiiqp lp find out mpm bioventures iiiqp lp address and contact details view other people related to mpm bioventures iiiqp lp  coworkers colleagues companions etc address co mpm asset management  clarendon st th floor boston  ma companies related to mpm bioventures iiiqp lp cikcompany namepositioncompany addressepirus biopharmaceuticals inc boylston st th floor boston altimmune inc firstfield road gaithersburg pernix sleep inc owner  stevens avenue suite  solana beach enteromedics inc owner  patton rd st paul aryx therapeutics inc owner  dumbarton circle fremont radius health incattn chief financial officer  winter street waltham  mpm bioventures iiiqp lp on the web persons related to mpm bioventures iiiqp lp  epirus biopharmaceuticals incnamepositioncityam coinvestors iii lpmenlo parkam coinvestors iii lpmenlo parkam partners iii llcmenlo parkam partners iii llc owner menlo parkam ventures iii lpmenlo parkam ventures iii lpmenlo parkrichard aldrichbostonrichard aldrichdirector cambridgeangiotech pharmaceuticals incvancouverangiotech pharmaceuticals inc vancouverlynn g bairdsenior vp  regulatory affairs cambridgelynn g bairdsenior vp  regulatory affairs cambridgelynn g bairdsenior vp  reg affairs cambridgelynn g bairdsenior vp  regulatory affairs cambridgelynn g bairdsvp regulatory affairs cambridgejohn v balenrowaytonbiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund l pchicagobiotechnology value fund l pchicagodavid bondermanfort worthdavid bondermanfort worthalexis borisypresident  ceo bostonalexis borisyceo  president cambridgealexis borisyceo  president cambridgealexis borisyceo  president cambridgej kevin buchidirector j kevin buchidirector bostonbvf incilchicagobvf incilsan franciscobvf incilchicagobvf investments llcchicagobvf investments llcchicagobvf partners l pil owner san franciscobvf partners l pil owner chicagobvf partners l pilchicagocanaan equity ii entrepreneurs llcrowaytoncanaan equity ii entrepreneurs llcrowaytoncanaan equity ii lp qprowaytoncanaan equity ii lp qprowaytoncanaan equity ii lprowaytoncanaan equity ii lprowaytoncanaan equity partners ii llcrowaytoncanaan equity partners ii llc owner rowaytoncanaan equity partners ii llcrowaytoncharmers landing llcrowaytongallen christophercambridgedouglas coledirector bostonjason colesenior vp and general counsel bostonjason colesenior vp  general counsel cambridgejason colesenior vp  gencounsel cambridgejason colesenior vp  general counsel cambridgejason colesvp  general counsel cambridgejason colesenior vp  general counsel cambridgejason coleevpcorp dev  general counsel cambridgemark corrigandirector marlboroughmark corrigandirector bostonmark corriganpresident  ceo cambridgemark corrigandirector cambridgemark corriganpresident  ceo cambridgejames g coulterfort worthjames g coulterfort worthsally crawforddirector cambridgesally crawforddirector cambridgekamra deepakrowaytonmark j deninowaynebarbara deptuladirector bostonbarbara deptuladirector cambridgebarbara deptuladirector cambridgejohn d diekmanmenlo parkjohn d diekmanmenlo parkgeoffrey m duykdirector geoffrey m duykfort worthtodd foleycambridgetodd foleydirector cambridgetodd foleydirector cambridgerobert forresterexecutive vp  cfo bostonrobert forresterexecutive vp  cfo cambridgerobert forresterevp and cfo cambridgerobert forresterevp  cfo cambridgerobert forresterevp  cfo cambridgerobert forresterevp  cfo cambridgerobert forresterevp and coo cambridgepatrick j fortunedirector bostonpatrick j fortunedirector cambridgepatrick j fortunedirector cambridgehaydu frankcambridgedaotian fudirector gongbei zhuhai city guangdongjames c furnivallrowaytonansbert gadickebostonnicholas galakatosbostonchristopher c gallenevp research  development cambridgechristopher c gallenevp research  development cambridgechristopher c gallenevp research  development cambridgejacob goldfielddirector bostondaniel grausen vp commercial operations bostondaniel grauchief operating officer cambridgedaniel grauchief operating officer cambridgedaniel grauchief operating officer cambridgedaniel grauchief operating officer cambridgel stephen greenrowaytonrichardson hartleycambridgefrank haydudirector cambridgefrank haydudirector cambridgefrank haydubostonfrank haydudirector cambridgefrank haydudirector cambridgedennis hennerbostonwilliam l hunterdirector vancouverwilliam l hunterdirector cambridgewilliam l hunterdirector cambridgewilliam l hunterdirector cambridgewilliam l hunterdirector bostoncole jasoncambridgerenz justincambridgemichael kauffmandirector cambridgemichael kauffmandirector cambridgemichael kauffmandirector cambridgemichael kauffmandirector cambridgecurtis t keithsenior vp discovery bostoncurtis t keithsenior vp research cambridgecurtis t keithsvp research cambridgerobert e keith jrwaynegregory kopchinskyrowaytonmark n lampertchicagojan lessemexecutive vp  cmo bostonjan lessemexecutive vp  cmo cambridgelivzon mabpharm incgongbei zhuhai guangdongcorrigan markcambridger eric mcallistersenior vp clinical development bostonjulie mchughdirector chadds fordjulie mchughdirector bostonkauffman michaelcambridgechristopher mollerdirector waynemontreux equity partners iv lpsan franciscomontreux equity partners iv lp owner san franciscomontreux equity partners v lpsan franciscomontreux equity partners v lpsan franciscompm asset management investors  bviii llcbostonmpm asset management llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii llc owner bostonmpm bioventures iii parallel fund lpbostonamit munshichief executive officer bostonwilliam j osheadirector cambridgewilliam j osheadirector cambridgewilliam j osheadirector cambridgerichard f popsbostonrichard f popsdirector cambridgerichard f popsdirector cambridgejohn randlecambridgejohn randlesvp commercial development cambridgejustin a renzcambridgejustin a renzsvp  chief financial officer cambridgejustin a renzsvp  cfo cambridgejustin a renzevp cfo  treasurer cambridgehartley t richardsondirector cambridgehartley t richardsondirector cambridgehartley t richardsondirector cambridgescott m rocklagedirector lincolnscott m rocklagebostonscott m rocklagedirector bostonseth rudnickdirector bostonguy m russorowaytonguy m russorowaytoncrawford sallycambridgeandrew j schwabmenlo parkandrew j schwabmenlo parkkim sethchief business officer bostonthomas a sheachief financial officer bostonnicholas j simon iiibostonterrance p snutchsvp  chief scientific officer cambridgeterrance p snutchsvp  cso cambridgemichael steinmetzbostonstonehenge llcrowaytonrobert ticktingeneral counsel bostontl ventures v interfund lpwaynetl ventures v llcwaynetl ventures v lp owner waynetl ventures v management lpwaynefoley toddcambridgetpg group holdings sbs advisors inc owner fort worthtpg group holdings sbs advisors incfort worthaurentz vincentchief business officer bostonoshea wcambridgewaubeeka llcrowaytonkurt wheelerbostonhunter williamcambridgec eugene wrightsvp  chief dev officer cambridgec eugene wrightdirector cambridgemichael wyandpresident and coo bostoneric a youngrowaytoneric a young owner rowaytonpersons related to mpm bioventures iiiqp lp  altimmune incnamepositioncityeric aguiarprincetonedward b bergerdes moinesedward b bergertucsonchristopher c camutvp govt contracts annapolisjames h cavanaughdirector princetonlinda l changsvp cfo  secretary annapolislinda l changsvp cfo  secretary annapolisreinhart charles iiiannapoliscamut christopherannapolisfrancesca m cooksvp policy  govt affairs annapolisfrancesca m cooksvp policy  govt affairs annapolisfrancesca m cooksvp policy  govt affairs annapoliselizabeth czerepaksee remarks germantownelizabeth czerepakdirector new yorkwright davidannapolisschaffer deraceannapolisschaffer deraceannapolisdavid drutzdirector raleighisrael a englandernew yorkwilliam enrightsee remarks gaithersburgrichman ericannapolisrichman ericannapoliscook francescaannapoliscook francescaannapolisphil frohlichtulsaphil frohlichtulsaphil frohlichtulsaphil frohlichtulsathomas richard fuerstevp chief scientific officer annapolisjoan fuscosvp operations annapolisjoan fuscosvp operations annapolisansbert gadickebostonnicholas galakatosbostonjohn gilldirector annapolisjohn gilldirector annapolisjohn gilldirector annapolisjohn gilldirector annapolishealthcare partners vii lpprincetonhealthcare partners vii lpprincetonhealthcare ventures vii lp owner princetonhealthcare ventures vii lp owner princetondennis hennerbostonphilip hodgesdirector gaithersburgcavanaugh jamesannapoliscavanaugh jamesannapolisrunge jeffreyannapolisfusco joanannapolisfusco joanannapolismccleary joelannapolismccleary joelannapolisgill johnannapolisgill johnannapolispappajohn johnannapolispappajohn johnannapolisjeffrey michael jonescoo annapoliskarp jordanannapoliskarp jordanannapolisjordan p karpsvp general counsel annapolisjordan p karpsvp general counsel annapolisjordan p karpsvp general counsel annapolismatthew p kinleydes moinesmatthew p kinleypresident  treasurer des moinesmatthew p kinleypresident  treasurer des moinesmatthew p kinleypresident  treasurer des moinesmatthew p kinleypresident and treasurer des moinesaugustine lawlorcambridgejohn w littlechildcambridgephilip macneillvp cfo treasurer secretary annapolisbrian a markisondirector annapolisbrian a markisondirector annapolisbrian a markisondirector annapolisjoel mcclearydirector annapolisjoel mcclearydirector annapolisjoel mcclearydirector annapolismillennium management llcnew yorkchristopher mirabellicambridgesayare mitchelannapoliswayne morgesvp regulatory affairs  qual annapoliswayne morgesvp regulatory affairs  qual annapoliswayne morgessvp reg affairs  quality annapolismpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii llc owner bostonmpm bioventures iii lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lpbostonag novartisch baselnovartis bioventures ltdhamiltonjohn pappajohnchairman and secretary des moinesjohn pappajohndirector annapolisjohn pappajohndirector annapolisjohn pappajohndirector annapolisjohn pappajohndes moinesjohn pappajohnchairman and secretary des moinesjohn pappajohnchairman and secretary des moinesjohn pappajohnchairman and secretary des moinesparadigm venture partners lpgaithersburgprescott group capital management llctulsaprescott group capital management llctulsaprescott group capital management llc owner tulsakevin pricepresidentpharmathene uk ltd billinghamkevin pricepresident  pharmathene ukltd billinghamredmont vaxn capital holdings llcgaithersburgredmont venture partners incgaithersburgcharles a reinhart iiiannapolischarles a reinhart iiisvp chief financial officer annapolischarles a reinhart iiisvp chief financial officer annapoliseric i richmandirector new yorkeric i richmansee remarks annapoliseric i richmansee remarks annapoliseric i richmanpresident and ceo annapolisvalerie d riddlesvp medical director annapolism scot robertschief scientific officer gaithersburgjeffrey w rungedirector annapolisjeffrey w rungedirector annapolisjeffrey w rungedirector annapolismitchel sayaredirector cambridgemitchel sayareannapolisklaus schaferdirector gaithersburgderace l schafferdirector rochesterderace l schaffervice chairman and ceo des moinesderace l schaffervice chairman and ceo des moinesderace l schafferdirector annapolisderace l schafferdirector annapolisderace l schafferdes moinesderace l schafferdirector des moinesderace l schaffervice chairman and ceo des moineswayne a schellhammerirvingnicholas j simon iiibostonpeter steven stdirector new yorkpeter steven stdirector bostonpeter steven stdirector annapolispeter steven stdirector annapolismichael steinmetzbostonst peter stevenannapolisst peter stevenannapolissybil taskerchief medical officer gaithersburgfuerst thomasannapolisriddle valerieannapolisriddle valerieannapolismorges wayneannapolismorges wayneannapolisharold r wernerprincetonharold r wernerprincetonkurt wheelerbostondavid p wrightpresident and ceo annapolispersons related to mpm bioventures iiiqp lp  pernix sleep incnamepositioncitymichael d allensvp sales and marketing san diegoba venture partners vi llcfoster citybavp lp owner foster citybavp lp owner foster cityjames c blair owner princetonjames c blair owner princetonlouis c bockdirector foster citylouis c bockfoster citylouis c bockfoster cityboxer asset management incnew providenceboxer asset management incnew providenceboxer capital llc del mardorsey briansolana beachmark j brooksfoster cityterrell cobbsan diegoterrell cobbdirector san diegoterrell cobbdirector san diegoterrell cobbdirector san diegoterrell cobbdirector san diegoterrell cobbdirector san diegoterrell cobbdirector solana beachkenneth m cohenpresident and ceo san diegokenneth m cohenpresident and ceo san diegohale davidsolana beachmanagement co ny deerfieldnew yorkdeerfield mgmt lpnew yorkdeerfield special situations fund lpnew yorkdeerfield special situations international master fund lpnew yorkassociates domainprincetondomain partners vi lp owner princetondomain partners vi lp owner princetonbrian dorseyvp product development san diegobrian dorseysvp technical operations san diegobrian dorseysvp technical operations san diegobrian dorseysvp technical operations san diegobrian dorseysvp technical operations san diegobrian dorseysvp technical operations solana beachbrian h dovey owner princetonbrian h dovey owner princetondp vi associates lp owner princetonsusan dubesenior vp corp and bus dev san diegosusan dubesenior vp corp and bus dev san diegomichael l eagledirector san diegomichael l eagledirector san diegomichael l eagledirector san diegomichael l eagledirector solana beachmichael l eagledirector san diegokurt von emsterdirector san diegokurt von emsterdirector solana beachkurt von emsterdirector south san franciscokurt von emsterbostonkurt von emsterdirector san diegokurt von emsterdirector south san franciscokurt von emsterdirector san diegokurt von emsterdirector san diegomast erlesolana beachluke evnin owner bostonjames e flynnnew yorkansbert gadickebostonansbert gadickebostonnicholas galakatosbostonnicholas galakatosbostoncam l garnerdirector san diegocam l garnerdirector san diegocam l garnerdirector san diegoscott l glenndirector san diegoscott l glenndirector san diegoscott l glenndirector san diegodavid f haledirector carlsbaddavid f haledirector san diegodavid f haledirector san diegodavid f haledirector solana beachdavid f haledirector san diegodavid f haleexecutive chairman san diegodavid f haledirector san diegofaheem hasnaindirector san diegofaheem hasnaindirector san diegofaheem hasnaindirector solana beachdennis hennerbostondennis hennerbostonraser jeffreysolana beachtreu jesseprincetonphilip jochelsonsenior vp and chief medical san diegophilip jochelsonsenior vp and chief medical san diegorobert lewis jonesvp of human resources san diegowheeler kurtsolana beachvon emster kurtsolana beachjoseph lewisnew providencejoseph lewisnew providencejames j litaliensvp regulatory affairs  qa san diegoerle t mastdirector san diegoerle t mastdirector solana beacherle t mastdirector san diegoerle t mastdirector san diegoerle t mastdirector san diegoonaitis matthewsolana beachmeg mcgilleyvp cfo treasurer secretary san diegomeg mcgilleyvp cfo treasurer san diegoeagle michaelsolana beachkate mitchellfoster citymontreux equity management ii sbic llcmenlo parkmontreux equity management ii sbic llcmenlo parkequity managment sbic montreux iiimenlo parkequity managment sbic montreux iiimenlo parkmontreux equity partners ii sbic lpmenlo parkmontreux equity partners ii sbic lp owner menlo parkmontreux equity partners iii sbic l pmenlo parkmontreux equity partners iii sbic l probert j more owner princetonrobert j more owner princetonmpm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii lpbostonmpm bioventures iii llc owner bostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lp owner bostonmva investors llcdel martran nguyenvice president and cfo solana beachtran nguyensvp and cfo san diegotran nguyensvp and cfo san diegotran nguyensvp and cfo san diegotran nguyensvp and cfo solana beachtran nguyensvp and cfo solana beachrory odriscollfoster citymatthew onaitisvice president legal affairs san diegomatthew onaitisvp general counsel san diegomatthew onaitissvp general counsel san diegomatthew onaitissvp general counsel san diegomatthew onaitissvp general counsel san diegomatthew onaitissvp general counsel san diegomatthew onaitissvp general counsel solana beachmatthew onaitissvp general counsel solana beachhoward d palefskymenlo parkhoward d palefskymenlo parkhoward d palefskymenlo parkrichard w pascoepresident and ceo san diegorichard w pascoepresident and ceo san diegorichard w pascoepresident and ceo san diegorichard w pascoepresident and ceo san diegorichard w pascoepresident and ceo san diegorichard w pascoepresident and ceo solana beachjeffrey rasersenior vp sales and marketing san diegojeffrey rasersenior vp sales and marketing san diegojeffrey rasersvp chief commercial officer san diegojeffrey rasersvp chief commercial officer san diegopascoe richardsolana beachscale venture management i llcfoster citykathleen k schoemaker owner princetonkathleen k schoemaker owner princetonnicholas j simon iiibostonnicholas j simon iiibostonmichael steinmetzbostonmichael steinmetzbostoncobb terrellsolana beachwiggans thomassolana beachjesse i treudirector princetonjesse i treudirector princetondaniel k turner iiimenlo parkdaniel k turner iiimenlo parkdaniel k turner iiidirector san diegodaniel k turner iiidirector san diegodaniel k turner iiidirector san diegonicole vitullo owner princetonnicole vitullo owner princetonkurt wheelerdirector san diegokurt wheelerdirector san diegokurt wheelerbostonkurt wheelerdirector bostonkurt wheelerdirector san diegothomas g wiggansdirector san diegothomas g wiggansdirector san diegothomas g wiggansdirector san diegothomas g wiggansdirector san diegopersons related to mpm bioventures iiiqp lp  enteromedics incnamepositioncityaberdare gp ii llc owner san franciscoaberdare gp ii llcsan franciscoaberdare ii annex fund l p owner san franciscoaberdare ii annex fund l psan franciscoaberdare ventures ii bermuda lpsan franciscoaberdare ventures ii lp owner san franciscoaberdare ventures ii lp owner san franciscodonders adrianusst paulnaqeeb a ansarisvp of sales st paulbay city capital fund iv co invesment fund lpsan franciscobay city capital fund iv co invesment fund lpsan franciscobay city capital fund iv co invesment fund lpsan franciscobay city capital fund iv lpsan franciscobay city capital fund iv lpsan franciscobay city capital fund iv lpsan franciscobay city capital fund iv lpsan franciscobay city capital llc owner san franciscobay city capital llc owner san franciscobay city capital llc owner san franciscobay city capital management iv llcsan franciscobay city capital management iv llcsan franciscobay city capital management iv llcsan franciscogary blackforddirector eden prairiegriffin bobbyst paulgriffin bobbyst paulmichael d boichmenlo parkgoldfischer carlst paulgoldfischer carlsan franciscoharvey b cashmenlo parkfriedman catherinest paulbruce a clevelandmenlo parkgladney danst paulpeter m delangesvp ops  bus dev st paulharrison donaldst pauladrianus donderssr vp of research  adv dev st pauldouglas family trustlarkspurkevin douglas owner larkspurmichelle douglaslarkspurchristopher b ehrlichmenlo parkkoskinas ellenmenlo parkruss felkeysr vpclinicalqualregaffair minneapoliscathy friedmandirector santa claracathy friedmandirector st paulansbert gadicke owner bostonnicholas galakatosbostonblackford garyst paulsander gerbernew yorkphilip t gianosmenlo parkdan w gladneychrm pres  ceo new brightoncarl goldfischerdirector san franciscocarl goldfischerdirector new yorkcarl goldfischerdirector san franciscocarl goldfischerdirector san franciscolinda s graismenlo parklea gregst paulbobby ivan griffindirector golden valleybobby ivan griffindirector st paulbradford c hancockst pauldonald c harrisondirector st pauldennis hennerbostonhfr master trustshamilton hm hfr master trustshamilton hm paul f hickeysvp of mktg  reimb st paulw stephen holmesmenlo parkhudson bay capital management lp owner new yorkhudson bay fund lpnew yorkhudson bay fund lpnew yorkhudson bay overseas fund ltdnew yorkinterwest management partners ix llc owner menlo parkinterwest partners ix lp owner menlo parkjames  jean douglas irrevocable descendants trustlarkspuranthony p janszdirector st paultremmel jonst paultremmel jonst paulkgd  annuity trust vilarkspurkgd  annuity trust vilarkspurnina s kjellsonmenlo parkgilbert h klimanmenlo parkpaul h klingensteindirector palo altopaul h klingensteindirector san franciscopaul h klingensteindirector san franciscopaul h klingensteindirector san franciscomark b knudsondirector st paulgary s kohlerminneapolisellen e koskinasdirector menlo parkellen e koskinasdirector menlo parkgregory s leacfo and cco rochestergregory s leasvp  cfo and coo minneapolismcdougal lorist paulevnin lukebostonknudson markst paulmarxe austin w  greenhouse david m owner new yorklori courtney mcdougaldirector st paulmmd  annuity trust vilarkspurmmd  annuity trust vilarkspurmpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lp owner bostonansari naqeebst paulh ronald nashmenlo parkkhaled nasrmenlo parkteti nicholasst paulteti jr nicholasst paulrajesh nihalanichief technology officer st paularnold l oronskymenlo parkpandora select partners lpminneapolishickey paulst paulklingenstein paulsan franciscodouglas a peppermenlo parkdelange peterst paulnihalani rajeshst paulthomas l roschmenlo parkyoungstrom scottst paulscott a shikoraevp  chief medical officer st paulnicholas j simon iiibostonmichael steinmetzbostonmichael b sweeneymenlo parknicholas tetidirector santa barbaranicholas tetidirector minneapolisjon t tremmeldirector st pauljon t tremmeldirector st paulkatherine s twedenvp  clinical and regulatory st paulvictor a westerlindmenlo parkkurt wheelerbostonwhitebox advisors llc owner minneapoliswhitebox ls equity partners lpminneapoliswhitebox multistrategy partners lpminneapoliswhitebox small cap long short equity advisors llcminneapoliswhitebox small cap long short equity partners lpminneapolisscott p youngstromcfo  cco new brightonpersons related to mpm bioventures iiiqp lp  aryx therapeutics incnamepositioncityrobert j adelmandirector fremontrobert j adelmandirector fremontjason barkersrdir principal acctg off fremontm james barrettbaltimorem james barretttimoniumpeter j barrisbaltimorepeter j barristimoniumforest baskettbaltimoreforest baskett owner timoniumdavid w beierdirector fremontdaniel canafaxvp  cdo fremontcanafax danielfremontbeier davidfremontnagler davidfremontryan d drantbaltimoreryan d drant owner timoniumpascal druzgalasr vp  chief scienoff fremontlars ekmandirector fremontlars ekmandirector fremontansbert gadickebostonnicholas galakatosbostonpaul goddardchairman  ceo fremontgrowth equity opportunities fund llcbaltimoregrowth equity opportunities fund llc owner timoniumdennis hennerbostonrosenman hermfremontrosenman hermnfremontsamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew york nyvarian johnfremontleonard keithfremontpatrick j kerinsbaltimorepatrick j kerins owner timoniumkrishna kittu kolluribaltimorekrishna kittu kolluri owner timoniumc richard kramlichbaltimorec richard kramlichtimoniumekman larsfremontkeith r leonarddirector fremontkeith r leonarddirector fremontcharles m linehanbaltimorepeter g milnerpres research  dev fremontmpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lp owner bostonmpm bioventures strategic fund lpbostondavid naglervpcorp affairs  sect fremontnea  gp llcbaltimorenea  gp llctimoniumpartners  limited partnership neabaltimorepartners  limited partnership neatimoniumenterprise associates  limited partnership newbaltimoreenterprise associates  limited partnership newtimoniumcharles w newhall iiibaltimorecharles w newhall iiitimoniumsimon nickfremontnomura phase ventures lplondonnomura phase ventures ltd owner londonorbimed advisors llc owner new yorkdruzgala pascalfremontdruzgala pascalfremontgoddard paulfremontsekhri paulfremontmark w perrybaltimoremark w perrytimoniummilner peterfremontherm rosenmandirector fremontherm rosenmandirector fremontscott d sandellbaltimorescott d sandelltimoniumpaul j sekhridirector fremontnicholas j simon iiidirector bostonnicholas j simon iiidirector fremontmichael steinmetzbostoneugene a trainor iiibaltimorejohn variancoo  cfo fremontkurt wheelerbostonpersons related to mpm bioventures iiiqp lp  radius health incnamepositioncityauerbach alancambridgegadicke ansbertcambridgealan h auerbachdirector los angelesalan h auerbachdirector cambridgealan h auerbachdirector walthamharvey bcambridgebiotech ag bbschaffhausenbiotech ag bbschaffhausen switzerlandbiotech ag bbschaffhausengrowth n v biotech owner curacogrowth n v biotech owner curacaolouis md brennerchief medical officer cambridgebrookside capital investors l pbostonbrookside capital management llc owner bostonbrookside capital partners fund lpbostonbrookside capital partners fund lpbostonlyttle ccambridgejose carmonachief financial officer newtown squarejames h cavanaughprincetonjames h cavanaughcambridgewillard h deredirector thousand oakswillard h derewalthamwillard h deredirector walthamashley l dombkowskisouth san franciscomark durandcambridgestoner elizabethcambridgeluke evnin bostonluke evnin owner bostonluke evninbostonf bio ventures gp ltdroad town tortolaf bio ventures gp ltdtortolaf bio ventures gp ltdroad town tortolaf bio ventures v lproad town tortolaf bio ventures v lptortolaf bio ventures v lproad town tortolaf bioscience gp ltdgeorge townf bioscience iii lp owner george townf bioscience iv gp ltdgeorge townf bioscience iv gp ltdgeorge townf bioscience iv lp owner george townf bioscience iv lp owner george townf bioscience vi lpgeorge townf capital ltdgeorge townf capital ltd owner tortolaf capital ltdtortolaf capital ltdtortolalorraine a fitzpatrickchief medical officer walthamjonathan flemingdirector cambridgejonathan flemingcambridgetodd foleycambridgetodd foleybostonmichael frankencambridgecathy friedmandirector santa claraandrew j fromkincambridgeansbert gadickedirector bostonansbert gadickedirector walthamansbert gadickedirector bostonansbert gadickebostonnicholas galakatos bostonnicholas galakatos owner bostonnicholas galakatos owner bostonjean pierre garnierdirector hartfordhattersley garycambridgeglobeways holdings ltdroad town tortolaglobeways holdings ltdtortolaglobeways holdings ltdroad town tortolakurt gravesdirector cambridgekurt gravescambridgekurt gravesdirector cambridgekurt gravesdirector walthamwilliam greenesouth san franciscoalan g harrischief medical officer cambridgealan g harrischief medical officer walthambrian nicholas harveysr vp and cfo cambridgebrian nicholas harveysr vp  cfo sec  treasurer cambridgebrian nicholas harveysr vice president  cfo walthamgary hattersleychief scientific officer cambridgegary hattersleysr vp  chief scientific off cambridgegary hattersleychief scientific officer walthambrent hatzisschochsr vp general counsel walthamhealthcare partners vii lpprincetonhealthcare partners vii lpcambridgeprivate equity limited partnership healthcareedinburghhealthcare ventures vii lpprincetonhealthcare ventures vii lp owner cambridgedennis hennersouth san franciscodennis hennerbostondennis hennerbostonjesper hoilandpresident and ceo walthamowen hughesdirector cambridgeowen hughesdirector walthampharma sas ipsenboulogne billancourtsa ipsenboulogne billancourtfleming jonathancambridgemorana jovanembiricosdirector cambridgemorana jovanembiricosdirector cambridgemorana jovanembiricosdirector walthamvaughn m kailianvaughn m kailianbostonvaughn m kailianbostongraves kurtcambridgeaugustine lawlorcambridgejohn w littlechildcambridgeodea louiscambridgececil richard lyttlepresident and ceo cambridgececil richard lyttlepresident and ceo cambridgececil richard lyttlecambridgemuenchbach martincambridgechristopher mirabellicambridgempm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm bio iv nvs strategic fund lpbostonmpm bio iv nvs strategic fund lpbostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii lpbostonmpm bioventures iii llc bostonmpm bioventures iii llc owner bostonmpm bioventures iii llc owner bostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lpbostonmpm bioventures iv gp llcbostonmpm bioventures iv gp llcbostonmpm bioventures iv llc owner bostonmpm bioventures iv llc owner bostonmartin muenchbachdirector san diegomartin muenchbachdirector cambridgemartin muenchbachdirector cambridgemartin muenchbachdirector cambridgemartin muenchbachdirector walthambioscience clinical development vii as nordicherlevbioscience clinical development vii as nordic owner herlevlouis odeacambridgekatherine priestleygeorge townkatherine priestleylondonkatherine priestleylondonkatherine priestleylondondinesh purandaresvp head of global oncology walthamanthony rosenbergdirector cambridgedebasish roychowdhurydirector walthamjames paul scopas san franciscojames paul scopasouth san francisconicholas j simon iiisouth san francisconicholas j simon iiibostonnicholas j simon iiibostondavid p snowchief commercial officer walthampeter steven stbostonpeter steven stbostonmichael steinmetzsan diegomichael steinmetzbostonmichael steinmetzbostonelizabeth stonerdirector bostonelizabeth stonerbostonelizabeth stonerdirector walthamvort john vanderbostonvort john vanderbostonvort john vanderbostonrob wardpresident  ceo palo altorobert wardpresident  ceo cambridgerobert wardpresident  ceo cambridgerobert wardpresident  chief exec officer walthamwellcome trust ltdlondon nw bewellcome trust ltd owner londonwellcome trust ltd the as trustee of the wellcome trust owner londonharold r wernerprincetonharold r wernercambridgekurt wheelerbostonkurt wheelerbostonkurt wheelerbostongregory c williamschief development officer cambridgegregory c williamschief development officer cambridgegregory c williamschief development officer walthammichael s wyzgachief executive officer cambridgejohn yatescambridgejohn yateschief medical officer cambridge potentially same personnamecitycountrympm bioventures iiiqp lpbostonmampm bioventures iiiqp lpbostonma   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied mpm bioventures iii qp lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors mpm bioventures iii qp lp check out list of companies and businesses related to mpm bioventures iii qp lp find out mpm bioventures iii qp lp address and contact details view other people related to mpm bioventures iii qp lp  coworkers colleagues companions etc address co mpm asset management  huntington ave st floor boston  ma companies related to mpm bioventures iii qp lp cikcompany namepositioncompany addressrigel pharmaceuticals inc owner  veterans boulevard south san francisco metabasis therapeutics inc towne centre drive san diego cotherix inc owner  shoreline court suite  south san francisco cornerstone therapeutics inc owner  crescent green drive suite  cary barrier therapeutics inc owner  college road east suite  princeton tercica inc sierra point parkway suite  brisbane radius health incattn chief financial officer  winter street waltham  mpm bioventures iii qp lp on the web persons related to mpm bioventures iii qp lp  rigel pharmaceuticals incnamepositioncityalta biopharma management ii llcsan franciscoalta biopharma partners ii lpsan franciscoalta california management partners lpsan franciscoalta california partners lpsan franciscoalta embarcadero biopharma partners ii llcsan franciscoalta embarcadero partners llcsan franciscopartners altasan franciscoalta partners ii inc owner san franciscobiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund ii lpchicagobiotechnology value fund l pchicagobiotechnology value fund l pchicagobiotechnology value fund l pchicagobvf incilchicagobvf incilchicagobvf incilchicagobvf investments llcchicagobvf investments llcchicagobvf investments llcchicagobvf partners l pil owner chicagobvf partners l pil owner chicagobvf partners l pilchicagofarah champsisan franciscorobin d g coopersr vp pharmaceutical scs south san franciscorobin d g coopersr vp pharmaceutical scs south san franciscodeerfield capital lpnew yorkdeerfield international ltdtortolamanagement co ny deerfieldnew yorkdeerfield partners lpnew yorkdeerfield special situations fund international ltdroad town tortoladeerfield special situations fund lpnew yorkjean deleagedirector south san franciscojean deleagedirector san franciscojean deleagedirector san franciscoannemarie duliegechief medical officer palo altokurt von emsterbostonluke evnin owner bostonluke evninbostonfhm iv llcseattlefhm iv lpseattlejames e flynn owner new yorkalan d frazierdirector seattlealan d frazierdirector seattlealan d frazierdirector seattlealan d frazierdirector seattlealan d frazierdirector seattlefrazier healthcare iv lp owner seattleansbert gadicke owner bostonansbert gadickebostonnicholas galakatos owner bostonnicholas galakatosbostonbradford s goodwindirector south san franciscobradford s goodwindirector south san franciscobradford s goodwindirector south san franciscojames m gowerceo  board chairman south san franciscojames m gowerceo  board chairman south san franciscoelliot b grossbardevp cmo south san franciscoelliot b grossbardsr vp medical development south san franciscoelliott b grossbardevp cmo south san franciscogarrett gruenersan franciscodennis hennerdirector bostoninvestment  llcchicagokeith katkindirector san diegomark n lampertsan franciscomark n lampertsan franciscomark n lampertchicagojoseph lasagavp bus dev alliance mgmt south san franciscorobert liptakbostongary a lyonsdirector palo altogary a lyonsdirector south san franciscogary a lyonsdirector south san franciscoalix marduelsan franciscoesteban masudasr vp research south san franciscoeldon c mayer iiievp  chief commercial officer south san franciscoryan d maynardevp  cfo south san franciscoryan d maynardevp  cfo south san franciscowalter h moosdirector san diegowalter h moosdirector oaklandwalter h moosdirector menlo parkwalter h moosdirector south san franciscompm asset management investors  bviii llcbostonmpm bioequities fund gmbh  co kgbostonmpm bioequities gp llcbostonmpm bioequities gp lpbostonmpm bioequities master fund lp owner bostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gp lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostonguy p nohrasan franciscodonald g payanevp pres discoveryresearch south san franciscodonald g payanevp pres discoveryresearch south san franciscodonald g payanevp pres discoveryresearch south san franciscohollings rentondirector south san franciscohollings rentondirector richmondhollings rentondirector emeryvillehollings rentondirector south san franciscopeter s ringrosedirector south san franciscopeter s ringrosedirector south san franciscoraul r rodriguezceo president south san franciscoraul r rodriguezceo president south san franciscostephen a sherwindirector south san franciscostephen a sherwindirector south san franciscostephen a sherwindirector foster citystephen a sherwindirector south san franciscostephen a sherwindirector south san francisconicholas j simon iiidirector bostonnicholas j simon iiidirector bostonnicholas j simon iiidirector san franciscomichael steinmetz owner bostonmichael steinmetzbostondolly vanceevp corp affairs gc sect south san franciscodolly vanceevp corp affairs gc sect south san franciscojames h welchcfo vp  secretary south san franciscojames h welchcfo vp  secretary south san franciscokurt wheelerbostonpersons related to mpm bioventures iii qp lp  metabasis therapeutics incnamepositioncityedgardo baracchini jrsan diegoedgardo baracchini jrsenior vp bus development san diegoedgardo baracchini jrsr vp of business development la jollaedgardo baracchini jrsr vp business development la jollajohn w becksan diegojohn w becksenior vp finance  cfo san diegojohn w beckchief financial officer la jollajohn w becksr vp finance  cfo la jollastephen c bowshermenlo parkstephen c bowshermenlo parkdaniel d burgessdirector san diegodaniel d burgessdirector san diegodaniel d burgessdirector la jolladaniel d burgessdirector la jollaharvey b cash owner dallasharvey b cashmenlo parkharvey b cashmenlo parkharvey b cashmenlo parksuisse credit owner new york ny suisse creditnew york ny suisse credit owner new york ny suisse credit owner new york ny suisse first boston credit owner new yorkmark d erionsan diegomark d erionchief executive officer la jollaluke evnindirector bostonluke evnindirector la jollaluke evnindirector la jollaluke evnindirector bostonhoward foytvice president la jollahoward foytvp of clinical development la jollawayne frostvp of regulatory affairs  qa la jollaansbert gadickebostonansbert gadickebostonnicholas galakatosbostonnicholas galakatosbostonphilip t gianosmenlo parkphilip t gianosmenlo parkphilip t gianosmenlo parkheinz w gschwenddirector santa rosaheinz w gschwenddirector san diegoheinz w gschwenddirector la jollabarry gumbinervp clinical development  cmo la jolladavid f haledirector carlsbaddavid f haledirector la jolladavid f haledirector la jollaw scott hedrickmenlo parkw scott hedrickmenlo parkw scott hedrickmenlo parkw stephen holmesmenlo parkw stephen holmesmenlo parkw stephen holmesmenlo parkinterwest investors vii lpmenlo parkinterwest investors vii lpmenlo parkinterwest investors vii lpmenlo parkinterwest management partners vii llcmenlo parkinterwest management partners vii llcmenlo parkinterwest management partners vii llcmenlo parkinterwest partners vii l p owner menlo parkinterwest partners vii l p owner menlo parkinterwest partners vii l p owner menlo parkgilbert h klimanmenlo parkgilbert h klimanmenlo parkgilbert h klimanmenlo parkpaul k laikindsan diegopaul k laikinddirector la jollapaul k laikindpresident ceo  secretary la jollatrisha millicanprincipal accounting officer la jollampm asset management ii llcbostonmpm asset management ii llcbostonmpm asset management ii lpbostonmpm asset management ii lpbostonmpm asset management investors b llcbostonmpm asset management investors b llcbostonmpm bioventures gmbh  co parallel beteiligungs kgbostonmpm bioventures ii gmbh  co parallel beteiligungs kgbostonmpm bioventures ii lpbostonmpm bioventures ii lpbostonmpm bioventures ii qp lp owner bostonmpm bioventures ii qp lp owner bostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gp lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostontran nguyenvp and cfo la jollaarnold l oronskydirector la jollaarnold l oronskydirector la jollaarnold l oronskydirector menlo parkarnold l oronskydirector menlo parkarnold l oronskydirector menlo parkwilliam r rohndirector la jollawilliam r rohndirector la jollawilliam r rohndirector san diegowilliam r rohndirector san diegothomas l roschmenlo parkthomas l roschmenlo parkthomas l roschmenlo parkgeorge schreinerdirector la jollasicor inc owner irvinemichael steinmetzbostonmichael steinmetzbostonelizabeth stonerdirector bostonkurt wheelerbostonkurt wheelerbostonpersons related to mpm bioventures iii qp lp  cotherix incnamepositioncityalta biopharma management iii llcsan franciscoalta biopharma management iii llcsan franciscoalta biopharma management iii llcsan franciscoalta biopharma partners iii gmbh  co beteiligungs kgsan franciscoalta biopharma partners iii gmbh  co beteiligungs kgsan franciscoalta biopharma partners iii gmbh  co beteiligungs kgsan franciscoalta biopharma partners iii lpsan franciscoalta biopharma partners iii lp owner san franciscoalta biopharma partners iii lp san franciscoalta california management partners iii llcsan franciscoalta california management partners iii llcsan franciscoalta california management partners iii llcsan franciscoalta california partners iii lpsan franciscoalta california partners iii lpsan franciscoalta california partners iii lpsan franciscoalta embarcadero biopharma partners iii llcsan franciscoalta embarcadero biopharma partners iii llcsan franciscoalta embarcadero biopharma partners iii llcsan franciscoalta embarcadero partners iii llcsan franciscoalta embarcadero partners iii llcsan franciscoalta embarcadero partners iii llcsan franciscoalta embarcadero partners iii llcsan franciscoalta partners ii inc owner san franciscoalta partners ii incsan franciscoalta partners ii incsan franciscoalta partners iii incsan franciscoalta partners iii incsan franciscoalain azansan franciscofarah champsisan franciscofarah champsisan franciscofarah champsisan franciscorobert chessdirector south san franciscorobert chessdirector south san franciscorobert chessdirector brisbanejean deleagesan franciscojean deleagesan franciscojean deleagesan franciscoklara dickinsonsouth san franciscoklara dickinsonvp regulatory affairs south san franciscoklara dickinsonvp regulatory affairs brisbaneluke evnin owner bostonthomas feldmanchief business officer south san franciscothomas feldmanpres and chief bus officer south san franciscothomas feldmanpresident  cbo brisbaneansbert gadickebostonansbert gadickebostonnicholas galakatosbostonnicholas galakatosbostonbradford s goodwindirector south san franciscobradford s goodwindirector south san franciscobradford s goodwindirector brisbanebradford s goodwindirector brisbanesmith christine grayexecutive vp cfo secretary south san franciscosmith christine grayevp chief financial officer south san franciscosmith christine grayexecutive vp cfo  secretary brisbanegarrett gruenersan franciscogarrett gruenersan franciscogarrett gruenersan franciscodavid w gryskadirector south san franciscodavid w gryskadirector brisbanejames healydirector san franciscojames healydirector san franciscodennis hennerbostondennis hennerbostonedward hurwitzsan franciscoedward hurwitzsan franciscodaniel janneydirector san franciscodaniel janneydirector san franciscodaniel janneydirector south san franciscodaniel janneydirector san franciscodaniel janneydirector brisbaneabhay joshievp chief technical officer south san franciscoabhay joshievp chief technical officer brisbanegeorge w mahaffeysouth san franciscogeorge w mahaffeysvp sales and marketing south san franciscogeorge w mahaffeysenior vp sales and marketing brisbanealix marduelsan franciscoalix marduelsan franciscoalix marduelsan franciscorobert s michitariansouth san franciscorobert s michitarianvp and gen counsel south san franciscompm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii llcbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostonmpm bioventures iii parallel fund lpbostonguy p nohrasan franciscoguy p nohrasan franciscoguy p nohrasan franciscoedward penhoetsan franciscoedward penhoetsan franciscojames e penningtonsouth san francsicojames e penningtonevp chief medical officer south san francsicojames e penningtonevp chief medical officer south san franciscojames e penningtonevpchief medical officer brisbanemichael powellsan franciscohoward b rosendirector south san franciscodonald j santelchief executive officer south san franciscodonald j santelchief executive officer south san franciscodonald j santelchief executive officer brisbanenicholas j simon iiidirector bostonnicholas j simon iiidirector bostonnicholas j simon iiidirector bostonnicholas j simon iiidirector bostonsofinnova management v llcsan franciscosofinnova venture affiliates v lpsan franciscosofinnova venture partners v lpsan franciscosofinnova venture principals v lpsan franciscomichael steinmetzbostonmichael steinmetzbostonkurt wheelerbostonkurt wheelerbostonpersons related to mpm bioventures iii qp lp  cornerstone therapeutics incnamepositioncityadvanced technology ventures vi lpwalthamadvanced technology ventures vi lpwalthamadvanced technology ventures vi lpwalthamadvanced technology ventures viib lpwalthamadvanced technology ventures viib lpwalthamadvanced technology ventures viib lpwalthamadvanced technology ventures viic lpwalthamadvanced technology ventures viic lpwalthamadvanced technology ventures viic lpwalthamadvanced technology ventures vii lpwalthamadvanced technology ventures vii lp owner walthameric aguiarcambridgeroberts alancarypowell andrewcaryfailla antoncaryatv alliance  lpwalthamatv alliance  lpwalthamatv alliance associates llcwalthamatv associates vi llcwalthamatv associates vi llcwalthamatv associates vii llcwalthamatv associates vii llcwalthamatv entrepreneurs vi lpwalthamatv entrepreneurs vi lpwalthamatv entrepreneurs vi lpwalthamatv entrepreneurs vii lpwalthamatv entrepreneurs vii lpwalthamatv entrepreneurs vii lpwalthamchenyqua michele baldwinvice president finance carycarolina pharmaceuticals holdings ltdhamiltoncarolina pharmaceuticals ltdthe valleyjames h cavanaughprincetonalessandro chiesiparmaalessandro chiesidirector parmafarmaceutici spa chiesi owner parmamaria paola chiesiparmachiesi us corpparmacodeanne christophercarychristopher george codeannecarychristopher george codeannedirector carycraig a collardpresident and ceo carycraig a collardchief executive officer carycornerstone biopharma holdings ltd owner carycollard craigcarywilliam crouseprincetonbrian dicksonchief medical officer carybrian dicksonchief medical officer caryira duarteprincipal accounting officer caryira duarteprincipal accounting officer caryrichard w dugandirector lexingtonmichael david enrightdirector carymichael david enrightcarygeorge arthur esgrovice president sales caryluke evnin bostonluke evninbostonanton giorgio faillaparmaanton giorgio failladirector parmafrederick finneganlexingtonfrederick finnegansvp of sales and marketing lexingtonjoshua b franklinvp strategy  bus dev caryansbert gadickebostonansbert gadicke bostonnicholas galakatosdirector bostonnicholas galakatosdirector bostonjean georgedirector lexingtonjean georgedirector walthamjean georgedirector walthamjean georgedirector walthamjames a harperdirector caryjames a harperdirector caryhealthcare partners vi lpprincetonhealthcare ventures vi lp owner princetonmichael thomas heffernandirector carymichael thomas heffernandirector carydana charles hiltsvp of clinical develop  cmo lexingtonharper jamescaryjohnson  johnson owner new brunswickjohnson  johnson development corp et alnew brunswickthomas patrick kellycfo  svp finance  corp dev lexingtonmcbean kennethcaryshawver lauracaryaugustine lawlorcambridgejohn w littlechildcambridgesteven michael lutzexecutive vice president carysteven michael lutzexecutive vice president caryandreas maetzelvp clinical and regulatory caryandreas maetzelvp clinical and regulatory caryvecchia marcocarykenneth mcbeanpresident carykenneth mcbeanpresident caryalastair stuart mcewandirector caryalastair stuart mcewancfo and treasurer carymedimmune ventures inc owner gaithersburgenright michaelcaryheffernan michaelcarychristopher miraellicambridgechristopher miraelliprincetonchristopher miraellidirector cambridgevincent t morgusevp finance and cfo carympm asset management ii llcbostonmpm asset management ii llcbostonmpm asset management ii lpbostonmpm asset management ii lpbostonmpm asset management investors  llcbostonmpm asset management investors  llcbostonmpm asset management investors  bviii llcbostonmpm bioventures ii gmbh  co parallel beteiligungs kgbostonmpm bioventures ii gmbh  co parallel beteiligungs kgbostonmpm bioventures ii lpbostonmpm bioventures ii lpbostonmpm bioventures ii qp lp owner bostonmpm bioventures ii qp lp bostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gp lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonwalter newmanchief scientific officervp rd lexingtonwalter newmancsosvp research  development lexingtontrevor phillipsformer president  ceo lexingtonandrew kenneth william powellevp general counsel carydavid pricechief financial officer carydavid pricechief financial officer carystephan robertcaryalan robertsvp scientific affairs caryalan robertsvp scientific affairs carypaul d rubinpresident and ceo lexingtonlaura shawverdirector carylaura shawverdirector carymichael steinmetzbostonmichael steinmetz bostonrobert stephanparmarobert stephandirector parmajames b tananbaumpalo altojames b tananbaumdirector palo altofrank e thomaslexingtonfrank e thomaspresident  ceo lexingtonscott b townsendgeneral counsel and svp legal lexingtonscott b townsendgeneral counsel and evp legal caryscott b townsendgeneral counsel and evp legal carymarco vecchiadirector parmamorgus vincentcarychristopher t phd walshdirector lexingtonhowland shaw warrendirector lexingtonharold r wernerprincetonkurt wheelerbostonkurt wheeler bostonjeffrey e youngformer vp finance  cao lexingtonrobert h zeigerdirector lexingtonm cory zwerlingdirector carlislepersons related to mpm bioventures iii qp lp  barrier therapeutics incnamepositioncitysrinivas akkarajudirector menlo parksrinivas akkarajudirector menlo parksrinivas akkarajunew yorksrinivas akkarajudirector new yorksrinivas akkarajunew yorkalfred altomarichief operating officer princetonalfred altomarichief operating officer princetonalfred altomarichief executive officer princetonbengal acquisition inc owner coral gablesmarcel borgerschief scientific officer b geelalbert bristowgeneral counsel and secretary princetonalbert bristowgeneral counsel and secretary princetonalbert bristowgeneral counsel  corp secy princetonrobert e campbelldirector north brunswickrobert e campbelldirector princetongeert cauwenberghchief executive officer princetongeert cauwenberghchief executive officer princetongeert cauwenberghdirector princetonanthony l craigwaynechristopher j daviswaynemark j deninowaynecarl ehmanndirector charlestoncarl ehmanndirector princetonedward l ericksondirector princetonedward l ericksondirector princetonpeter ernsterdirector princetonpeter ernsterdirector princetonluke evnin owner bostonansbert gadickebostonnicholas galakatosbostondennis hennerbostonj p morgan chase  conew yorkj p morgan partners global investors a lpnew yorkj p morgan partners global investors a lpnew yorkj p morgan partners global investors cayman ii lpnew yorkj p morgan partners global investors cayman ii lpnew yorkj p morgan partners global investors cayman ii lpnew yorkj p morgan partners global investors cayman lpnew yorkj p morgan partners global investors cayman lpnew yorkj p morgan partners global investors cayman lpnew yorkcharles f jacey jrdirector belle meadcharles f jacey jrdirector princetonjanssen pharmaceutica products lpnew brunswickjanssen pharmaceutica products lpnew brunswickjanssen pharmaceutica products lpnew brunswickjohnson  johnson owner new brunswickjohnson  johnson consumer companies incnew brunswickjohnson  johnson consumer companies incnew brunswickjohnson  johnson consumer companies incnew brunswickjohnson  johnson development corp et alnew brunswickjohnson  johnson development corp et alnew brunswickjp morgan partners bhca lp owner new yorkjp morgan partners bhca lp owner new yorkjp morgan partners bhca lp owner new yorkjp morgan partners bhca lp owner new yorkjp morgan partners bhca lp owner new yorkjp morgan partners global investors lpnew yorkjp morgan partners global investors lpnew yorkjp morgan partners global investors lpnew yorkjp morgan partners global investors lpnew yorkmorgan partners global investors selldown llp jpnew yorkmorgan partners global investors selldown llp jpnew yorkmorgan partners global investors selldown llp jpnew yorkjpmp capital corpnew yorkjpmp capital corpnew yorkjpmp capital corpnew yorkjpmp global investors l pnew yorkjpmp global investors l pnew yorkjpmp global investors l pnew yorkjpmp global investors l pnew yorkjpmp master fund manager l pnew yorkjpmp master fund manager l pnew yorkjpmp master fund manager l pnew yorkrobert e keith jrwaynechristopher mollerwaynempm asset management investors  bviii llcbostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gp lpbostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostoncharles nomideschief rd officer princetoncharles nomideschief rd officer princetoncharles nomideschief rd officer princetonmarc j ostrodirector waynefrank h pearlwashingtonfrank h pearlwashingtonfrank h pearlwashingtonperseus biotech fund partners llcwashingtonperseus biotech fund partners llcwashingtonperseus ec llcwashingtonperseus soros biopharmaceutical fund lp owner new yorkperseus soros biopharmaceutical fund lp new yorkperseus soros biopharmaceutical fund lpnew yorkperseus soros partners llcwashingtonperseus soros partners llcnew yorkperseus soros partners llcnew yorkperseuspur llcwashingtonperseuspur llcwashingtoncarol raphaeldirector princetoncarol raphaeldirector princetondennis reillyprincetondennis reillyvp finance  pao princetondennis reillychief financial officer princetondr drew schiffnew yorksfm ah llcnew yorksfm ah llcnew yorksfm ah llcnew yorksfm participation lpnew yorksfm participation lpwashingtonsfm participation lpnew yorksfm participation lpnew yorkbraham shrootchief scientific officer princetonnicholas j simon iiidirector bostonnicholas j simon iiidirector bostonsoros fund management llcnew yorksoros fund management llcnew yorkgeorge sorosnew yorkgeorge sorosnew yorkmichael steinmetzbostoncharles w stiefelcoral gablescharles w stiefelcoral gablesstiefel laboratories inccoral gablesstiefel laboratories inc owner coral gablestl ventures v interfund lpwaynetl ventures v llcwaynetl ventures v lp owner waynetl ventures v management lpwayneanne vanlentexec vp cfo and treasurer princetonanne vanlentexec vp cfo and treasurer princetonanne vanlentexec vp  cfo princetonkurt wheelerbostonpersons related to mpm bioventures iii qp lp  tercica incnamepositioncitymichael j astruedirector brisbaneajay bansalchief financial officer brisbanealexander e barkasdirector palo altoalexander e barkasdirector palo altoalexander e barkasdirector palo altoalexander e barkasdirector palo altoalexander e barkasdirector palo altojean luc belingarddirector parisgeorge m brightsouth san franciscoross g clarksouth san franciscoross g clarkchief technical officer south san franciscoross g clarkchief technical officer brisbaneashley l dombkowskisouth san franciscodrakensberg lpnew yorkkarin easthamsan diegokarin easthamdirector south san franciscokarin easthamdirector brisbaneluke evninsouth san franciscoluke evnin owner bostonansbert gadickebostonansbert gadickebostonnicholas galakatosbostonnicholas galakatosbostonandrew j grethleinsouth san franciscoandrew j grethleinvice president manufacturing south san franciscoandrew j grethleinsvp pharmacetical operations brisbanefaheem hasnaindirector brisbanedennis hennersouth san franciscodennis hennerdirector bostondennis hennerdirector bostondennis hennerdirector bostondennis hennerdirector bostonrussell c hirschpalo altorussell c hirschpalo altowayne t hockmeyergaithersburgwayne t hockmeyersouth san franciscosa ipsenparissa ipsen owner parisolle isakssongoteborg swedenolle isakssondirector south san franciscochristophe jeandirector parischristophe jeandirector boulogne billancourthabib kairouznew yorkhabib kairouznew yorkkariba llcnew yorkrichard kingpresident and coo brisbanemark leschlynew yorkmark leschlydirector new yorkmark leschlydirector new yorktimothy p lynchsouth san franciscotimothy p lynchchief financial officer south san franciscodavid l mahoneydirector south san franciscodavid l mahoneydirector brisbanempm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii llc owner bostonmpm bioventures iii llcbostonmpm bioventures iii lpbostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostonmpm bioventures iii parallel fundbostonmichael j parkersouth san franciscomichael j parkervice president quality south san franciscoprospect associates ii l ppalo altoprospect associates ii l ppalo altoprospect associates ii l ppalo altoprospect management co ii llcpalo altoprospect management co ii llcpalo altoprospect venture partners ii lp owner palo altoprospect venture partners ii lp owner palo altorho capital partners incnew yorkrho capital partners incnew yorkcapital partners verwaltungs gmbh rhonew yorkcapital partners verwaltungs gmbh rhonew yorkrho management trust inew yorkrho management trust inew yorkrho management ventures iv llcnew yorkrho management ventures iv llcnew yorkrho ventures iv gmbh  co beteiligungs kgnew yorkrho ventures iv gmbh  co beteiligungs kgnew yorkrho ventures iv lpnew yorkrho ventures iv qp lpnew yorkrho ventures iv qp lp owner new yorkchristopher eugene riverasnr vp commercial operations south san franciscochristopher eugene riverasnr vp commercial operations brisbanestephen rosenfieldsenior vp of legal affairs south san franciscostephen rosenfieldexecutive vp of legal affairs brisbanestephen rosenfieldevp legal affairs gc  sec brisbanejoshua ruchnew yorkjoshua ruchnew yorkjohn a scarlettsouth san franciscojohn a scarlettchief executive officer south san franciscojohn a scarlettchief executive officer brisbanedavid schnellpalo altodavid schnellpalo altothomas h silbergchief operating officer south san francisconicholas j simon iiisouth san francisconicholas j simon iiibostonmichael steinmetzbostonmichael steinmetzbostonsas suraypharmparisjames b tananbaumpalo altojames b tananbaumpalo altostein thorsten vonsvp and chief medical officer south san franciscostein thorsten vonsvp and chief medical officer brisbaneira wallissouth san franciscokurt wheelersouth san franciscokurt wheeler owner bostonthomas g wiggansdirector south san franciscothomas g wiggansdirector brisbanesusan wongsouth san franciscosusan wongacting chief financial officer south san franciscosusan wongvp finance  chief acctg offcr brisbanecarl worrellsouth san franciscopersons related to mpm bioventures iii qp lp  radius health incnamepositioncityauerbach alancambridgegadicke ansbertcambridgealan h auerbachdirector los angelesalan h auerbachdirector cambridgealan h auerbachdirector walthamharvey bcambridgebiotech ag bbschaffhausenbiotech ag bbschaffhausen switzerlandbiotech ag bbschaffhausengrowth n v biotech owner curacogrowth n v biotech owner curacaolouis md brennerchief medical officer cambridgebrookside capital investors l pbostonbrookside capital management llc owner bostonbrookside capital partners fund lpbostonbrookside capital partners fund lpbostonlyttle ccambridgejose carmonachief financial officer newtown squarejames h cavanaughprincetonjames h cavanaughcambridgewillard h deredirector thousand oakswillard h derewalthamwillard h deredirector walthamashley l dombkowskisouth san franciscomark durandcambridgestoner elizabethcambridgeluke evnin bostonluke evnin owner bostonluke evninbostonf bio ventures gp ltdroad town tortolaf bio ventures gp ltdtortolaf bio ventures gp ltdroad town tortolaf bio ventures v lproad town tortolaf bio ventures v lptortolaf bio ventures v lproad town tortolaf bioscience gp ltdgeorge townf bioscience iii lp owner george townf bioscience iv gp ltdgeorge townf bioscience iv gp ltdgeorge townf bioscience iv lp owner george townf bioscience iv lp owner george townf bioscience vi lpgeorge townf capital ltdgeorge townf capital ltd owner tortolaf capital ltdtortolaf capital ltdtortolalorraine a fitzpatrickchief medical officer walthamjonathan flemingdirector cambridgejonathan flemingcambridgetodd foleycambridgetodd foleybostonmichael frankencambridgecathy friedmandirector santa claraandrew j fromkincambridgeansbert gadickedirector bostonansbert gadickedirector walthamansbert gadickedirector bostonansbert gadickebostonnicholas galakatos bostonnicholas galakatos owner bostonnicholas galakatos owner bostonjean pierre garnierdirector hartfordhattersley garycambridgeglobeways holdings ltdroad town tortolaglobeways holdings ltdtortolaglobeways holdings ltdroad town tortolakurt gravesdirector cambridgekurt gravescambridgekurt gravesdirector cambridgekurt gravesdirector walthamwilliam greenesouth san franciscoalan g harrischief medical officer cambridgealan g harrischief medical officer walthambrian nicholas harveysr vp and cfo cambridgebrian nicholas harveysr vp  cfo sec  treasurer cambridgebrian nicholas harveysr vice president  cfo walthamgary hattersleychief scientific officer cambridgegary hattersleysr vp  chief scientific off cambridgegary hattersleychief scientific officer walthambrent hatzisschochsr vp general counsel walthamhealthcare partners vii lpprincetonhealthcare partners vii lpcambridgeprivate equity limited partnership healthcareedinburghhealthcare ventures vii lpprincetonhealthcare ventures vii lp owner cambridgedennis hennersouth san franciscodennis hennerbostondennis hennerbostonjesper hoilandpresident and ceo walthamowen hughesdirector cambridgeowen hughesdirector walthampharma sas ipsenboulogne billancourtsa ipsenboulogne billancourtfleming jonathancambridgemorana jovanembiricosdirector cambridgemorana jovanembiricosdirector cambridgemorana jovanembiricosdirector walthamvaughn m kailianvaughn m kailianbostonvaughn m kailianbostongraves kurtcambridgeaugustine lawlorcambridgejohn w littlechildcambridgeodea louiscambridgececil richard lyttlepresident and ceo cambridgececil richard lyttlepresident and ceo cambridgececil richard lyttlecambridgemuenchbach martincambridgechristopher mirabellicambridgempm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm asset management investors  bviii llcbostonmpm bio iv nvs strategic fund lpbostonmpm bio iv nvs strategic fund lpbostonmpm bioventures iii gmbh  cobostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii gp lpbostonmpm bioventures iii lpbostonmpm bioventures iii lpbostonmpm bioventures iii llc bostonmpm bioventures iii llc owner bostonmpm bioventures iii llc owner bostonmpm bioventures iii lpbostonmpm bioventures iii parallel fundbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iiiqp lpbostonmpm bioventures iiiqp lpbostonmpm bioventures iv gp llcbostonmpm bioventures iv gp llcbostonmpm bioventures iv llc owner bostonmpm bioventures iv llc owner bostonmartin muenchbachdirector san diegomartin muenchbachdirector cambridgemartin muenchbachdirector cambridgemartin muenchbachdirector cambridgemartin muenchbachdirector walthambioscience clinical development vii as nordicherlevbioscience clinical development vii as nordic owner herlevlouis odeacambridgekatherine priestleygeorge townkatherine priestleylondonkatherine priestleylondonkatherine priestleylondondinesh purandaresvp head of global oncology walthamanthony rosenbergdirector cambridgedebasish roychowdhurydirector walthamjames paul scopas san franciscojames paul scopasouth san francisconicholas j simon iiisouth san francisconicholas j simon iiibostonnicholas j simon iiibostondavid p snowchief commercial officer walthampeter steven stbostonpeter steven stbostonmichael steinmetzsan diegomichael steinmetzbostonmichael steinmetzbostonelizabeth stonerdirector bostonelizabeth stonerbostonelizabeth stonerdirector walthamvort john vanderbostonvort john vanderbostonvort john vanderbostonrob wardpresident  ceo palo altorobert wardpresident  ceo cambridgerobert wardpresident  ceo cambridgerobert wardpresident  chief exec officer walthamwellcome trust ltdlondon nw bewellcome trust ltd owner londonwellcome trust ltd the as trustee of the wellcome trust owner londonharold r wernerprincetonharold r wernercambridgekurt wheelerbostonkurt wheelerbostonkurt wheelerbostongregory c williamschief development officer cambridgegregory c williamschief development officer cambridgegregory c williamschief development officer walthammichael s wyzgachief executive officer cambridgejohn yatescambridgejohn yateschief medical officer cambridge potentially same personnamecitycountrympm bioventures iii qp lpbostonmampm bioventures iii qp lpbostonmampm bioventures iii qp lpbostonma mpm bioventures ii qp lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active mpm bioventures ii qp lp • boston ma how do i update this listing mpm bioventures ii qp is based out of boston whalewisdom has at least  dg filings in our database for mpm bioventures ii qp summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from mpm bioventures ii qp lp enter your email address below and choose submit your email cancel contact info mpm bioventures ii qp lp the john hancock tower boston ma     business phone  recent sec filings sc ga filed on  sc g filed on  sc ga filed on  sc g filed on  sc g filed on  sc d filed on  sc d filed on  current dg holdings stock sector shares held market value rank source source date hemosense inc hem health care    g  restore medical inc rest health care    g  unknown unknown   d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free insider trading  mpm bioventures iiiqp lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  mpm bioventures iiiqp lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana radius health inc rdus mpm bioventures iii llchenner dennismpm asset management investors  bviii llcmpm bioventures iii gmbh  co beteiligungs kgmpm bioventures iii parallel fund lpmpm bioventures iii gp lpmpm bioventures iii lpmpm bioventures iiiqp lpsteinmetz michaelother   indirect view   secformcom all rights reserved archives        sat  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  sec info  mpm bioventures iiiqp lp et al  �� for  re pernix sleep inc  filing submission sec info uses javascript� to view pages properly enable javascript in your browser ����sec info������home������search������my interests������help������sign in������please sign in ��installed latest microsoft security patches� rebooting now� up as soon as possible� mpm bioventures iiiqp lp et al � ���for� re�pernix sleep incon� wednesday  at pm et � � � for�  � � � as�  owner � � � accession �  � � � file �  previous ‘’� ‘’ on  for  � � � next� ‘’ on  for  � � � latest� ‘’ on  for  ��in� this entire filing an entity search ��show� docs searched �and� every hit the st hit help�wildcards�  any letter�  many� logic� for docs� �and� �or� for text� �anywhere� �near� � ↓bottom � t as of filer filing for�on�as docssize issuer agent  mpm bioventures iiiqp lp   owner k pernix sleep inc rr donnelley filefa mpm bioventures iii lp mpm bioventures iii parallel fund lp mpm bioventures iii gmbh  co beteiligungs kg mpm bioventures iii gp lp mpm bioventures iii llcfinitial statement of beneficial ownership of securities � � � form filing table of contents documentexhibit description pages size   initial statement of beneficial ownership of html k securities  bsfbsfmpmxml filing submission  – sgml textraw sgmltagged text that was submitted by� donnelley financial solutions filefa �as�filing�agentshow all document text elements below� � � � � � � � � ↑top ↓bottom� submission                                                                     acceptancedatetime  accessionnumber  type  publicdocumentcount  period  filingdate  dateoffilingdatechange  reportingowner ownerdata conformedname mpm bioventures iii qp lp cik  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street  huntington avenue street st floor city boston state ma zip  phone    businessaddress formername formerconformedname mpm bio ventures iii qp lp datechanged  formername reportingowner issuer companydata conformedname somaxon pharmaceuticals inc cik  assignedsic  irsnumber  stateofincorporation de fiscalyearend  companydata businessaddress street  high bluff drive suite  city san diego state ca zip  phone   businessaddress mailaddress street  high bluff drive suite  city san diego state ca zip  mailaddress issuer reportingowner ownerdata conformedname mpm bioventures iii lp cik  stateofincorporation de fiscalyearend  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  phone    businessaddress mailaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  mailaddress formername formerconformedname mpm bio ventures iii lp datechanged  formername reportingowner reportingowner ownerdata conformedname mpm bioventures iii parallel fund lp cik  stateofincorporation de fiscalyearend  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  phone  businessaddress mailaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  mailaddress formername formerconformedname mpm bioventures iii parallel fund datechanged  formername formername formerconformedname mpm bio ventures iii parallel fund datechanged  formername reportingowner reportingowner ownerdata conformedname mpm bioventures iii gmbh  co beteiligungs kg cik  stateofincorporation m this is an secspecific code that maps to germany  fiscalyearend  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  phone  businessaddress mailaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  mailaddress formername formerconformedname mpm bioventures iii gmbh  co datechanged  formername formername formerconformedname mpm bio ventures iii gmbh  co datechanged  formername reportingowner reportingowner ownerdata conformedname mpm bioventures iii gp lp cik  stateofincorporation de fiscalyearend  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  phone  businessaddress mailaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  mailaddress formername formerconformedname mpm bio ventures iii gp lp datechanged  formername reportingowner reportingowner ownerdata conformedname mpm bioventures iii llc cik  fiscalyearend  ownerdata filingvalues formtype  act  filenumber  filmnumber  filingvalues businessaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  phone  businessaddress mailaddress street the john hancock tower street  clarendon street th floor city boston state ma zip  mailaddress formername formerconformedname mpm bio ventures iii llc datechanged  formername reportingowner submission↑top filing submission  � – � alternative formats word  rich text html plain text et�al copyright �  fran finnegan  company� all rights reservedabout – privacy – redactions – help — sun  jul  gmt� mpm capital  powering breakthroughs in life sciences mpm focus area personalized therapeutics forgenetically defined cancerwatch now chris bardon md oncology impact funddiscusses advances in cancer therapies bloomberg capital markets june  related investment epizyme companies mpm investment strategy mpm capital works with leading scientists to create companies that seek to address unmet needs and change the face of medicine across all therapeutic areas mpm is currently investing out of bv its most recent venture fund in  mpm partnered with ubs to create the ubs oncology impact fund oif an innovative impact investing fund focused exclusively on oncology that will invest in both private and public equities oif will support both basic cancer research as well as access to cancer care in developing countries fund all bv oncology impact fund investments current exited exit type all ipo ma focus area all oncology other andme genetic reports for consumers to better appreciate their ancestry other current  smallmolecule therapeutics that modulate mirnas for treatment oncology current affymax inc previously committed to developing novel drugs other exited aires clinical stage pharmaceutical company for pulmonary disorders other exited alinea pharmaceuticals inc previously developed new treatments for metabolic conditions other exited allozyne inc cancer and inflammatory disease therapeutic company oncology exited alnara orallydelivered protein therapeutics to treat metabolic diseases other exited amphivena developing bispecific tandabs as a novel immunotherapy for hematological disorders oncology current anthera developing drugs for autoimmune diseases other exited aratana provides innovative therapies for companion animals other current archus orthopedics inc previously developed implants to treat spine disorders other exited aryx therapeutics inc previously focused on molecular design other exited astute medical improving the diagnosis of highrisk medical conditions other current atopix therapeutics inc developing novel treatments for asthma other exited barrier therapeutics inc specialized in dermatological creams and gels other exited biomarin innovative therapeutics to patients with serious unmet medical needs other exited blade therapeutics a discovery stage company focused on developing fibrosis treatments other current celladon developing a transformative therapy for heart failure other exited cellerant therapeutics inc novel immunotherapies for oncology and bloodrelated disorders oncology exited cerecor inc developing innovative treatments for patients with cns disorders other exited ceregene inc development and manufacturing of gene therapies other exited cerimon pharmaceuticals inc developed and commercialized therapeutics for autoimmune diseases other exited chf solutions inc manufactures medical devices for cardiac care other exited chiasma developing oral drugs that were previously only available by injection other current clinical ink modernize clinical trials with esource  patient engagement tools other current conatus developing novel therapeutics for liver diseases other exited costim developing novel antibodies for cancer immunotherapy oncology exited cotherix inc licensing of therapeutic products for cardiopulmonary diseases other exited digitx partners digital health investment partnership with astellas pharma other current dragonfly sciences inc developing a new class of biosimilar products other exited ekr therapeutics provides acutecare specialty products other exited elixir pharmaceuticals inc develops novel pharmaceuticals for the treatment of metabolic diseases other exited endogastric solutions inc endoluminal treatment of gastroesophageal reflux disease other exited endologix provides optimal solutions for endovascular aortic repair other current enteromedics inc developer of vbloc® neurometabolic therapy other current epizyme personalized therapeutics for patients with genetically defined cancer oncology current fortebio develops analytical systems that enable realtime analysis of biomolecular interactions other exited harpoon therapeutics t cell redirection to deliver deep remissions oncology current helicos biosciences corporation genetic analysis for the research drug discovery and diagnostics other exited hypnion inc development of novel therapeutics for cns disorders other exited iconic developing therapeutics for serious eye disorders other current idenix discovers and develops drugs for human viral diseases other exited idun pharmaceuticals inc other exited innovative spinal technologies inc developed treatments for spinal disorders other exited intercell ag modern prophylactic and therapeutic vaccines other exited intracel holdings corporation development and commercialization of cancer vaccines other exited iomx therapeutics ag targeting t cell evasion to treat cancer oncology current ipierian developing antitau protein antibodies for neurodegenerative disease other exited kalobios pharmaceuticals inc developing monoclonal antibodies for cancer care oncology exited macrogenics inc oncology exited maverick therapeutics inc inducible t cellredirecting antibodies oncology current memory pharmaceuticals corp developed drug candidates for the treatment of cns disorders other exited meritage pharma treatment for eosinophilic esophagitis eoe other exited mitobridge discovers and develops novel drugs that enhance mitochondrial function other current motus therapeutics inc developing therapies for severe gastric mobility disorders other exited neosil manufactures dermatologyfocused specialty pharmaceutical products other exited neovista inc technologies for age related mucular degeneration other exited neuromed pharmaceuticals inc produces pain therapies in the us other exited nevro developing a highfrequency stimulation technology for chronic pain other exited oncorus developing a nextgeneration immunotherapy platform to treat cancer oncology current oxagen limited a privatelyheld biopharmaceutical company other current pacira acute care products including exparel for postsurgical analgesia other exited peptimmune inc designs peptides for therapeutics diagnostic kits  antibodies other exited pernix therapeutics inc specialty primary care and generic medicines other exited pharmasset discovering and developing novel drugs to treat viral infections other exited pharmathene inc acquire and develop products identified as urgent priorities other exited poniard pharmaceuticals inc discovery development and commercialization of oncology products other exited portola pharmaceuticals inc a biopharmaceutical company in the hematologic diseases fields other exited potenza therapeutics developing novel immunotherapies for the treatment of cancer oncology current proteon therapeutics developing a therapy to improve dialysis vascular access other current quatrx pharmaceuticals company treatment of moderate to severe dyspareunia fda approved in feb  other exited radius health novel differentiated therapeutics for patients with osteoporosis other current raze therapeutics developing novel antitumor agents through mitochondrial onecarbon me oncology current repare therapeutics targeting geneticallydefined cancer weaknesses oncology current rhythm developing peptide therapeutics for metabolic diseases other current rigel pharmaceuticals inc smallmolecule development for inflammatory and autoimmune diseases oncology exited rinat neuroscience corp develops treatment of diseases and disorders of the nervous system other exited sai drug discovery development and manufacturing services other exited selexys developing novel products to treat inflammatory diseases other exited semma therapeutics developing cellbased transformative therapies for diabetes patients other current sideris pharmaceuticals inc development of new treatments for transfusion related iron overload other exited solasia developing commercializing oncology  oncology supportive care drugs oncology exited somaxon pharmaceuticals inc developed silenor for treatment of insomnia other exited surface logix inc enhancing molecular functionality of pharmaceuticals other exited syndax developing and commercializing epigenetic therapies for cancer oncology current tcr inc focused on engineering t cells for cancer therapy oncology current tercica inc developed increlex for treatment of primary igf deficiency other exited tetherex pharmaceuticals corporation operates in the healthcare industry focusing on biotechnology business other current theraclone sciences inc screening technology for antibodies that ward off disease other exited tizona therapeutics inc regulatory t cell suppression as a novel approach to fighting cancer oncology current trieza therapeutics immunomodulatory oncolytic virus therapeutics oncology current trinetx platform to improve clinical research study design  recruitment other current true north therapeutics developing drugs which selectively inhibit the complement system other exited vaccinogen inc personalized vaccines to fight disease oncology other current valeritas marketing a disposable insulin delivery device other current vascular developing a novel antibody for diabetic nephropathy other current verastem inc treating cancer by the targeted killing of cancer stem cells oncology exited verus pharmaceuticals inc pediatricoriented specialty pharmaceutical company other exited xanodyne pharmaceuticals inc integrated specialty pharmaceutical company other exited mpm team mpms team is comprised of innovators entrepreneurs executives  investors role investment team medical  scientific advisors operations team location all cambridge san francisco patrick baeuerle patrick baeuerle phd managing director cambridge read bio chris bardon christiana bardon md managing director cambridge read bio vinay bhaskar vinay bhaskar phd principal san francisco read bio laura brass laura brass phd mba managing director cambridge read bio lauren cauley lauren cauley chief financial officer cambridge read bio thomas ebeling thomas ebeling medical and scientific advisor oif read bio stephen elledge stephen j elledge phd medical and scientific advisory board mpm  oif read bio luke evnin luke evnin phd managing director san francisco read bio mitchell finer phd mitchell finer phd managing director cambridge read bio todd foley todd foley mba managing director cambridge read bio shinichiro fuse shinichiro fuse phd principal cambridge read bio ansbert gadicke ansbert gadicke md managing director cambridge read bio bard geesaman bard geesaman md phd managing director cambridge read bio william greene william greene md venture partner san francisco read bio william hahn william c hahn md phd medical and scientific advisor oif read bio dan hicklin dan hicklin phd managing director cambridge read bio robert horvitz h robert horvitz phd medical and scientific advisory board mpm  oif read bio ed hurwitz ed hurwitz jd mba managing director san francisco read bio briggs morrison briggs morrison md managing director cambridge read bio vas narasimhan vas narasimhan md medical and scientific advisory board mpm read bio gary patou gary patou md managing director san francisco read bio sarah reed sarah reed chief operating officer and general counsel cambridge read bio tony rosenberg tony rosenberg managing director cambridge read bio david ryan david p ryan md medical  scientific advisor oif read bio kazumi shiosaki kazumi shiosaki phd managing director cambridge read bio greg sieczkiewicz greg sieczkiewicz jd phd managing director  chief ip counsel cambridge read bio elizabeth stoner elizabeth stoner md managing director cambridge read bio chris varma chris varma phd entrepreneurinresidence cambridge read bio contact us infompmcapitalcom cambridge ma  kendall street cambridge ma  phone   see full map  get directions san francisco ca  gateway boulevard suite  south san francisco ca  phone   see full map  get directions print terms of use  disclosures  june   semma therapeutics mentioned in wsj article “biotech startups’ cellbased diabetes attack” june   mpm and versant venture colead series a financing of repare therapeutics june   proteon therapeutics announces  million private placement june   visionary scientist stephen j elledge joins mpm capital’s medical and scientific advisory board june   accomplished oncologist and scientist william c hahn joins mpm capital’s oncology impact fund advisory board june   tcr therapeutics to debut positive solid tumor data on its novel truc™ engineered t cell platform at the world preclinical congress june   radius presents positive data from a fully enrolled ongoing phase i study for investigational drug elacestrant rad at the  american society of clinical oncology annual meeting asco may   amgen vet patrick baeuerle inspires a m round from alist vcs for a nextgen io drug platform may   harpoon therapeutics announces completion of m series b financing may   mpm portfolio company true north therapeutics acquired by bioverativ inc upfront payment of m plus assumed cash with additional payments of up to m contingent on the achievement of future milestones may   syndax shares soar as lead drug clears a midstage cancer drug study hurdle may   conatus announces exercise of license option for global development and commercialization of emricasan following notice of initiation of phase b encorelf clinical trial in nash cirrhosis may   inside perspectives on cancer immunotherapy an interview with mpm’s christiana bardon april   fda approves mpm portfolio company radius health’s tymlos™ abaloparatide bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture april   meet one the most successful german biotech leaders ever read more about mpm’s patrick baeuerle april   mpm managing director chris bardon named a top transformer top innovation gurus leading the biopharma industrys transformation are recognized by mmm april   mpm portfolio company oncorus nominated for  nevy award as hottest earlystage startup therapeutics april   syndax pharmaceuticals adds biopharmaceutical industry leader keith a katkin to board of directors february   rhythm announces completion of  million mezzanine financing — proceeds to finance significant expansion of genetic obesity clinical trials — february   chris varma cofounder and former president and ceo of blueprint medicines joins mpm as entrepreneurinresidence january   mpm portfolio company maverick therapeutics and takeda announce fiveyear collaboration to advance tcell engagement therapies january   accomplished biotech investor ed hurwitz joins mpm as managing director  december   mpm portfolio company astute medical forms strategic partnership with biotechne december   novartis signs exclusive option collaboration and license agreement with mpm portfolio company conatus pharmaceuticals inc december   oncorus® inc announces additional series a financing support from astellas venture management llc december   harpoon therapeutics appoints gerald mcmahon phd as president and ceo december   tcr therapeutics launches from stealth mode to accelerate development of novel cancer immunotherapies  m series a financing led by mpm capital and f ventures  december   chris bardon mpm managing director comments to bloomberg on new approaches to medical philanthropy read full article – “a few billionaires are turning medical philanthropy on its head” november   epizyme announces fast track designation for tazemetostat in dlbcl and provides tumor program update november   novartis acquires mpm portfolio company selexys pharmaceuticals corporation and selg antibody for reduction of pain crises in sickle cell disease november   harpoon therapeutics appoints hanspeter gerber phd as chief scientific officer november   semma therapeutics announces mark fishman md has joined its board of directors as chairman october   mpm portfolio company epizyme expands clinical programs through cooperative research and development agreements with the national cancer institute october   motus therapeutics inc a subsidiary of mpm portfolio company rhythm holding co llc is to be acquired by allergan acquisition announced following positive results for phase b clinical trial of treatment for gi disorders october   true north therapeutics announces  million series d financing financing follows encouraging interim clinical data announced for lead product candidate tnt in cold agglutinin disease october   true north therapeutics receives fda orphan drug designation for tnt for the treatment of autoimmune hemolytic anemia including cold agglutinin disease cad october   pacira pharmaceuticals’ kristen williams is honored as  of  “fierce women in biopharma ” learn why kristen stands out among women in the industry september   iomx therapeutics raises eur  million in series a round company establishes toptier investor base consisting of mpm capital sofinnova partners wellington partners and merck ventures september   three mpm portfolio companies blade oncorus  rhythm named to fiercebiotech’s “ fierce ” list september   radius announces publication of additional positive results from the phase  active trial of osteoporosis treatment september   tizona therapeutics inc appoints george golumbeski phd to its board of directors august   osteoporosis a disease with few treatment options may soon have one more read coverage in ny times and in press release august   aratana secures third fda approval animal pain drug expected to be available to veterinarians in the fall of  august   harvard medical school appoints mpm medical and scientific advisory cochair george daley as new dean read more in the boston globe august   iconic therapeutics announces final close of series c financing with additional  million investment august   astellas and mpm capital launch digitx partners july   mpm portfolio company blade therapeutics featured in the san francisco business times the july  article “taking it personally cutting–edge biotech snags  million” discusses the latest round of funding for blade a company focused on finding therapies for fibrotic disease and mpm cofounder luke evnin’s personal commitment to the cause july   rhythm announces new england journal of medicine publication of setmelanotide phase  data for treatment of pomc deficiency obesity significant weight loss with targeted treatment for patients with rare genetic defect in critical weight regulation pathway july   former bluebird bio blue cso takes the reins at oncorus startup launches with  million series a june   mpm portfolio company semma therapeutics featured in boston globe bostonarea hospitals have teamed up with the harvard stem cell institute and semma therapeutics to make personalized cellbased therapies and organize clinical trials june   chris bardon managing director for the oncology impact fund on bloomberg capital markets discussing advances in cancer therapies as the  asco annual meeting gets underway may   trinetx enters into collaboration with celgene advance clinical trial design and research for nextgeneration medicines planned may   aratana therapeutics granted fda approval of entyce® firstofitskind ghrelin mimetic may   mpm launches  million social impact oncology fund april   ubs cancer fund shows power of impact investing a new oncology fund will finance academic research and access to cancer care in developing countries april   ubs mpm seek big ‘impact’ in cancer drugs with m fund by marie powers bioworld today april   april   ubs raises record  million for oncology impact fund biospacecom  march   aratana therapeutics granted first fda approval galliprant for the control of pain and inflammation associated with osteoarthritis in dogs march   chiasma initiates phase  trial to support european registration of octreotide capsules for patients with acromegaly march   tizona therapeutics inc completes  million series b financing march   radius health submits new drug application to the us food and drug administration for abaloparatidesc for the treatment of postmenopausal women with osteoporosis march   nasdaq welcomes syndax parmaceuticals inc to the nasdaq stock market january   iconic therapeutics closes series c financing  october   cerecor announces pricing of initial public offering october   semma therapeutics named fiercemedicaldevices’  fierce  august   syndax enters clinical trial collaboration in cancer immunotherapy combining entinostat and atezolizumab august   syndax raises  million in series c financing august   rhythm subsidiary raises  million in oversubscribed financing financing to advance rhythm metabolic incs setmelanotide program for rare genetic disorders of obesity august   epizyme appoints robert bazemore president and chief executive officer july   chiasma inc prices initial public offering of common stock july   taking clinical trials out of the dark ages clinical ink june   briggs w morrison md ceo of syndax appointed key strategic advisor to mpm capital june   chiasma submits new drug application to us fda for octreotide capsules in acromegaly submission based on positive results from phase  clinical trial june   k peter hirth phd joins iconic therapeutics as board member and senior scientific advisor may   mpm capital appoints pablo j cagnoni md former onyx pharmaceuticals president as managing director and ceo of mpm immunotherapy portfolio company vesuvius may   mpm closes  million fund may   andme launches the lupus research study in collaboration with pfizer inc with lupus awareness month underway study aims to build a patient lupus cohort to advance understanding of the disease april   astellas pharma and potenza therapeutics partner to build a portfolio of immunooncology therapeutics exclusive collaboration includes option for astellas to acquire potenza april   novartis international global head ma and licensing anthony rosenberg to join as managing director effective april    to serve as strategic advisor and on mpm portfolio boards to build leading companies  march   biotech startup to fight diabetes on the cellular front semma therapeutics seeks to turn success in stem research lab into a way to encourage insulin production march   semma therapeutics announces  million in funding led by mpm capital to develop cell therapy for treating type  diabetes signs agreement with global pharmaceutical company march   ebb  flow chiasma’s private decision march   chiasma announces mark leuchtenberger as chief executive officer proven business leader to oversee commercialization of octreotide capsules march   andme to create therapeutics group appoints scientific luminary rd executive richard scheller phd to lead dr scheller joins andme’s executive leadership team as chief science officer and head of therapeutics march   mpm capital announces immunooncology pioneer patrick baeuerle to serve as managing director top scientist and drug developer joins mpm senior team advancing breakthroughs and discoveries march   radius rdus announced today that it has acquired the license to develop and market rad in japan dinesh purandare hired former sanofi sanpa oncology executive to the position of senior vice president svp and head of global oncology at radius  february   chiasma announces completion of  million series e financing february   verastem receives orphan drug designation from fda for vs in mesothelioma february   chiasma appoints david stack as chairman of the board john a scarlett md joins board of directors february   syndax says immunooncology discovery happened instead of an ipo february   chiasma inc releases newly published phase  study results show positive outcomes for octreotide capsules in people with acromegaly a serious hormonal disorder february   radius celladon and nevro among top ipos in  mpm has   and  out of the top  january   radius the top performing ipo of  radius which is developing treatments for osteoporosis is up  since pricing its june  initial public offering at   december   radius announces positive phase  topline results december   for venture capital biotech is where it’s really at august   aratana featured startups work on biotech drugs for pets july   cerecor inc closes on initial tranche of usm series b financing june   true north snags m and sets course for the clinic with a rare disease drug april   ipierian acquired by bristolmyers squibb advances discovery strategy to pursue therapeutics for genetically defined diseases april   iconic therapeutics raises  million to advance clinical development of wet amd program william greene md appointed chief executive officer april   celladon receives breakthrough therapy designation from fda mydicar is first gene therapy reported to receive breakthrough designation from fda’s center for biologics evaluation and research cber february   costim pharmaceuticals inc acquired by novartis january   mpm capital and kleiner perkins caufield  byers top the list of investors with the most  ipos january   epizyme and celgene advance epz dotl inhibitor clinical program to benefit cancer patients with acute leukemias achieving  million clinical proof of concept milestone     x x x   mpm bioventures iii lp private company information  bloomberg july    pm et capital markets company overview of mpm bioventures iii lp snapshot people company overview mpm bioventures iii lp specializes in early midstage latestage and pipe investments the fund focuses on healthcare biotechnology pharmaceutical medical device and platform technology companies  percent of its investments is focused on biotechnology and pharmaceutical products and  percent is focused on medical devices and the life science tool segment the fund seeks to invest in the united states europe and asia the fund prefers to invest between  million and  million per transaction  kendall streetcambridge ma united statesfounded in  phone  fax  key executives for mpm bioventures iii lp dr ansbert k gadicke md phd managing director and cofounder age  dr luke b evnin phd cofounder managing director and managing partner age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states bertelsmann ag europe the advertising council inc united states rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact mpm bioventures iii lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close